US EditionZimmer Biomet Receives FDA Clearance for Persona® Revision SoluTion™ Femur – Ortho Spine News
Summary by Ortho Spine News | Your Trusted Voice for Medical Device Industry Ortho News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Zimmer Biomet Receives FDA Clearance for Persona® Revision SoluTion™ Femur – Ortho Spine News
A Revision Knee Implant Alternative for Patients with Metal Sensitivities WARSAW, Ind., March 7, 2025 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Persona® Revision SoluTion Femur, a revision knee implant component offering an alternative for patients with sensitivities to certain metals. The Persona Revision SoluTio
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
